MIDAS (Modafinil in Debilitating Fatigue after Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

Stroke

Volumn 48, Issue 5, 2017, Pages 1293-1298

  Bivard, Andrew ^a,b   Lillicrap, Thomas ^a,b   Krishnamurthy, Venkatesh ^a,b   Holliday, Elizabeth ^b   Attia, John ^b,c   Pagram, Heather ^b   Nilsson, Michael ^b   Parsons, Mark ^a,b   Levi, Christopher R ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

anxiety; cognition; depression; fatigue; stroke

Indexed keywords

MODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ADULT; AGED; AGITATION; ANXIETY DISORDER; ARTICLE; ASSESSMENT OF HUMANS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION ANXIETY STRESS SCALE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONTREAL COGNITIVE ASSESSMENT; NAUSEA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STROKE PATIENT; STROKE SPECIFIC QUALITY OF LIFE SCALE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; CLINICAL TRIAL; COMPLICATION; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STROKE; WAKEFULNESS-PROMOTING AGENTS;

EID: 85017440286     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.016293     Document Type: Article

References (27)

1. Lerdal A, Gay CL. Fatigue in the acute phase after first stroke predicts poorer physical health 18 months later. Neurology. 2013;81:1581-1587. doi: 10.1212/WNL.0b013e3182a9f471.
2. Mücke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015;5:CD006788
3. Ingles JL, Eskes GA, Phillips SJ. Fatigue after stroke. Arch Phys Med Rehabil. 1999;80:173-178.
4. Wu S, Kutlubaev MA, Chun HYY, Cowey E, Pollock A, Macleod MR, et al. Interventions for post-stroke fatigue. Cochrane Database of Systematic Reviews 2015; 7:CD007030.
5. Arzt M, Young T, Peppard PE, Finn L, Ryan CM, Bayley M, et al. Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke. 2010;41:e129-e134. doi: 10.1161/STROKEAHA.109.566463.
6. Kuppuswamy A, Clark EV, Turner IF, Rothwell JC, Ward NS. Poststroke fatigue: a deficit in corticomotor excitability? Brain. 2015;138(pt 1):136-148. doi: 10.1093/brain/awu306.
7. Naess H, Lunde L, Brogger J, Waje-Andreassen U. Fatigue among stroke patients on long-term follow-up. The Bergen Stroke Study. J Neurol Sci. 2012;312:138-141. doi: 10.1016/j.jns.2011.08.002.
8. Egerton T, Chastin SF, Stensvold D, Helbostad JL. Fatigue may contribute to reduced physical activity among older people: An Observational Study. J Gerontol A Biol Sci Med Sci. 2016;71:670-676. doi: 10.1093/gerona/glv150.
9. Kutlubaev MA, Mead GE, Lerdal A. Fatigue after stroke-perspectives and future directions. Int J Stroke. 2015;10:280-281. doi: 10.1111/ijs.12428.
10. Gerrard P, Malcolm R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat. 2007;3:349-364.
11. Xiao YL, Fu JM, Dong Z, Yang JQ, Zeng FX, Zhu LX, et al. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin. 2004;25:301-305.
12. Piérard C, Satabin P, Lagarde D, Barrère B, Guezennec CY, Menu JP, et al. Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: a 2D COSY 1H-NMR study. Brain Res. 1995;693:251-256.
13. Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243-249. doi: 10.1159/000232927.
14. Poulsen MB, Damgaard B, Zerahn B, Overgaard K, Rasmussen RS. Modafinil may alleviate poststroke fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial. Stroke. 2015;46:3470-3477. doi: 10.1161/STROKEAHA.115.010860.
15. Lillicrap T, Krishnamurthy V, Attia J, Nilsson M, Levi CR, Parsons MW, et al. Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial. Trials. 2016;17:410. doi: 10.1186/s13063-016-1537-4.
16. Lin JM, Brimmer DJ, Maloney EM, Nyarko E, Belue R, Reeves WC. Further validation of the multidimensional fatigue inventory in a US adult population sample. Popul Health Metr. 2009;7:18. doi: 10.1186/1478-7954-7-18.
17. Smets EM, Garssen B, Bonke B. Manual; Multidimensional Fatigue Inventory. Amsterdam, the Netherlands: Medical Psychology, Academic Medical Center; 1995.
18. Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315-325.
19. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the Fatigue Severity Scale in a Swiss cohort. Sleep. 2008;31:1601-1607.
20. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123.
21. Ledinek AH, Sajko MC, Rot U. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis-result of a pilot randomized, blind study. Clin Neurol Neurosurg. 2013;115(Suppl 1):S86-S89. doi: 10.1016/j.clineuro.2013.09.029.
22. Sheng P, Hou L, Wang X, Wang X, Huang C, Yu M, et al. Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis. PLoS One. 2013;8:e81802. doi: 10.1371/journal.pone.0081802.
23. Duncan F, Greig C, Lewis S, Dennis M, MacLullich A, Sharpe M, et al. Clinically significant fatigue after stroke: a longitudinal cohort study. J Psychosom Res. 2014;77:368-373. doi: 10.1016/j. jpsychores.2014.06.013.
24. Kuppuswamy A, Clark EV, Turner IF, Rothwell JC, Ward NS. Poststroke fatigue: a deficit in corticomotor excitability? Brain. 2015;138(pt 1):136-148. doi: 10.1093/brain/awu306.
25. Kuppuswamy A, Clark EV, Sandhu KS, Rothwell JC, Ward NS. Post-stroke fatigue: a problem of altered corticomotor control? J Neurol Neurosurg Psychiatry. 2015;86:902-904. doi: 10.1136/jnnp-2015-310431.
26. Tanaka M, Ishii A, Watanabe Y. Neural mechanisms underlying chronic fatigue. Rev Neurosci. 2013;24:617-628. doi: 10.1515/revneuro-2013-0035.
27. Liepert J, Mingers D, Heesen C, Bäumer T, Weiller C. Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler. 2005;11:316-321. doi: 10.1191/1352458505ms1 163oa.